Pacer Advisors Inc. Decreases Stock Position in Nutex Health Inc. $NUTX

Pacer Advisors Inc. trimmed its position in shares of Nutex Health Inc. (NASDAQ:NUTX) by 13.9% in the first quarter, Holdings Channel.com reports. The firm owned 28,676 shares of the company’s stock after selling 4,613 shares during the period. Pacer Advisors Inc.’s holdings in Nutex Health were worth $2,725,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in NUTX. Bank of America Corp DE increased its stake in Nutex Health by 52.3% during the 1st quarter. Bank of America Corp DE now owns 9,027 shares of the company’s stock worth $858,000 after buying an additional 3,101 shares during the period. Smith Group Asset Management LLC purchased a new position in Nutex Health in the 1st quarter valued at about $1,244,000. EverSource Wealth Advisors LLC purchased a new position in Nutex Health in the 1st quarter valued at about $83,000. Empowered Funds LLC acquired a new stake in shares of Nutex Health during the first quarter valued at about $3,084,000. Finally, Quantinno Capital Management LP acquired a new stake in shares of Nutex Health during the first quarter valued at about $843,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Analyst Ratings Changes

NUTX has been the topic of a number of analyst reports. Zacks Research raised Nutex Health to a “hold” rating in a research report on Monday, June 29th. B. Riley Financial started coverage on Nutex Health in a report on Friday, June 26th. They issued a “buy” rating and a $290.00 price target for the company. Lake Street Capital started coverage on Nutex Health in a research note on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price objective for the company. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Finally, Wall Street Zen lowered Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 20th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $243.33.

Nutex Health Price Performance

Shares of NUTX stock opened at $162.07 on Friday. The firm has a fifty day moving average of $157.23 and a two-hundred day moving average of $129.20. The firm has a market cap of $1.12 billion, a P/E ratio of 6.36 and a beta of 0.24. Nutex Health Inc. has a 1-year low of $77.21 and a 1-year high of $204.00. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.